An engineered zinc finger protein reveals a role for the insulin VNTR in the regulation of the insulin and adjacent IGF2 genes.
An engineered zinc finger protein (eZFP) was isolated from a library based on its ability to activate expression of the endogenous insulin gene in HEK-293 cells. Using a panel of insulin promoter constructs, the eZFP was shown to act through the variable number of tandem repeat (VNTR) region located 365 base pairs upstream of the transcription start site. The eZFP also activated expression of the IGF2 gene that lies close to INS on chromosome 11p15. These results demonstrate that the INSVNTR controls expression of the insulin and IGF2 genes and provide a mechanistic explanation for previous studies that demonstrated an association between INSVNTR genotypes and placental levels of IGF2.
Ferguson
Laura A
LA
School of Medical Sciences, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK.
Docherty
Hilary M
HM
MacKenzie
Amanda E
AE
Docherty
Kevin
K
D002460:Cell Line; D044127:Epigenesis, Genetic / Q000187:drug effects; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000235:genetics*; D007335:Insulin-Like Growth Factor II / Q000235:genetics*; D018598:Minisatellite Repeats / Q000187:drug effects / Q000235:genetics*; D015202:Protein Engineering; D011506:Proteins / Q000138:chemical synthesis / Q000302:isolation & purification / Q000494:pharmacology; D024363:Transcription Initiation Site; D016335:Zinc Fingers
C035170:IGF2 protein, human; D007328:Insulin; D011506:Proteins; D007335:Insulin-Like Growth Factor II